Evidence map›Paper›PMID 26090808›Full record

ArticlePloS one2015

Ginseng Berry Extract Promotes Maturation of Mouse Dendritic Cells.

Wei Zhang, Si-Young Cho, Gao Xiang, Kyung-Jin Min, Qing Yu, Jun-O Jin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Adaptogenic effects ofJournal of ginseng research · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Wei ZhangShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Si-Young ChoR&D Unit, AmorePacific Corporation, 1920 Yonggudae-ro, Giheung-gu, Yongin-si, Gyeonggi-do, Korea.
Gao XiangModel Animal Research Center, Nanjing University, Nanjing, China.
Kyung-Jin MinDepartment of Biological Sciences, Inha University, Incheon, Korea.
Qing YuDepartment of Immunology and Infectious Diseases, The Forsyth Institute, 245 First Street, Cambridge, MA, United States of America.
Jun-O JinShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Shanghai Public Health Clinical Center · CNAmorepacific (South Korea) · KRInha University · KRNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginseng extract has been shown to possess certain anti-virus, anti-tumor and immune-activating effects. However, the immunostimulatory effect of ginseng berry extract (GB) has been less well characterized. In this study, we investigated the effect of GB on the activation of mouse dendritic cells (DCs) in vitro and in vivo. GB treatment induced up-regulation of co-stimulatory molecules in bone marrow-derived DCs (BMDCs). Interestingly, GB induced a higher degree of co-stimulatory molecule up-regulation than ginseng root extract (GR) at the same concentrations. Moreover, in vivo administration of GB promoted up-regulation of CD86, MHC class I and MHC class II and production of IL-6, IL-12 and TNF-α in spleen DCs. GB also promoted the generation of Th1 and Tc1 cells. Furthermore, Toll like receptor 4 (TLR4) and myeloid differentiation primary response 88 (MyD88) signaling pathway were essential for DC activation induced by GB. In addition, GB strongly prompted the proliferation of ovalbumin (OVA)-specific CD4 and CD8 T cells. Finally, GB induced DC activation in tumor-bearing mice and the combination of OVA and GB treatment inhibited B16-OVA tumor cell growth in C57BL/6 mice. These results demonstrate that GB is a novel tumor therapeutic vaccine adjuvant by promoting DC and T cell activation.

Indexed as

AnimalsAntigen PresentationCell DifferentiationDendritic CellsDisease Models, AnimalFruitLymphocyte ActivationMiceMice, KnockoutMyeloid Differentiation Factor 88NeoplasmsPanaxPlant ExtractsSignal TransductionT-Lymphocytes, Helper-InducerToll-Like Receptor 4Myeloid Differentiation Factor 88Plant ExtractsToll-Like Receptor 4

Identifiers

PMID26090808
PMCPMC4474810
OpenAlexW2257440385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.